Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-22 Option Award |
2025-02-24 5:43 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director |
5,369 | $0 | 22,570 (Direct) |
View |
| 2025-02-19 Option Award |
2025-02-21 4:47 pm |
N/A 2035-02-19 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director |
11,771 | $0 | 28,972 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 5:04 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director |
3,886 | $0 | 17,201 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 5:02 pm |
N/A 2034-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director |
13,621 | $0 | 26,936 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 5:01 pm |
N/A 2033-02-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director |
10,179 | $0 | 23,494 (Direct) |
View |
| 2023-02-22 Option Award |
2023-02-24 5:12 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director |
3,882 | $0 | 13,315 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 9:24 pm |
2023-02-22 2032-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director |
10,729 | $0 | 20,162 (Direct) |
View |
| 2022-02-19 Option Award |
2022-02-23 4:19 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director |
4,222 | $0 | 9,433 (Direct) |
View |
| 2021-02-19 Option Award |
2021-02-23 6:46 pm |
2022-02-19 2031-02-19 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director |
11,587 | $0 | 16,798 (Direct) |
View |